{"version":"1.0","provider_name":"Canadian Partnership Against Cancer","provider_url":"https:\/\/www.partnershipagainstcancer.ca\/fr\/","author_name":"Catherine","author_url":"https:\/\/www.partnershipagainstcancer.ca\/fr\/author\/cjan\/","title":"Description textuelle du graphique comparant les taux de rappel pour anomalie \u00e0 l\u2019\u00e9chelle internationale - Canadian Partnership Against Cancer","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"tXLwgUC08p\"><a href=\"https:\/\/www.partnershipagainstcancer.ca\/fr\/text-description-international-abnormal-call-rates\/\">Description textuelle du graphique comparant les taux de rappel pour anomalie \u00e0 l\u2019\u00e9chelle internationale<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/www.partnershipagainstcancer.ca\/fr\/text-description-international-abnormal-call-rates\/embed\/#?secret=tXLwgUC08p\" width=\"600\" height=\"338\" title=\"&laquo;&nbsp;Description textuelle du graphique comparant les taux de rappel pour anomalie \u00e0 l\u2019\u00e9chelle internationale&nbsp;&raquo; &#8212; Canadian Partnership Against Cancer\" data-secret=\"tXLwgUC08p\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/www.partnershipagainstcancer.ca\/wp-includes\/js\/wp-embed.min.js\n\/* ]]> *\/\n<\/script>\n","description":"Le graphique sur la page Situation actuelle en mati\u00e8re de TRA dans le contexte du d\u00e9pistage du cancer du sein au Canada\u00a0compare les taux de rappel pour anomalie pour les d\u00e9pistages initiaux et subs\u00e9quents du cancer du sein dans six pays : Au Canada, en\u00a02012, le taux de rappel \u00e9tait de\u00a015,8\u00a0% pour les d\u00e9pistages initiaux [&hellip;]"}